ASSOCIATION OF FC-GAMMA RECEPTOR POLYMORPHISM CD16A AND CLINICAL BENEFITS OF ELOTUZUMAB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE.
CLINICAL PHARMACOLOGY & THERAPEUTICS（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined